{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:15:30Z","timestamp":1761862530329,"version":"3.38.0"},"reference-count":24,"publisher":"American Veterinary Medical Association (AVMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p><jats:bold>Objective<\/jats:bold>\u2014To evaluate the effect of oral administration of dexamethasone (DEX) at clinically relevant doses on metabolic activities of cytochrome P450 (CYP) isoenzymes in dogs and rats.<\/jats:p>\n<jats:p><jats:bold>Animals<\/jats:bold>\u201415 healthy 1-year-old male Beagles and 20 healthy 10-week-old male Wistar rats.<\/jats:p>\n<jats:p><jats:bold>Procedure<\/jats:bold>\u2014Hepatic microsomes were harvested from dogs treated orally with DEX at 2.5 and 7.5 mg for 5 days and from rats treated orally with DEX at 0.75, 6, and 48 mg\/kg for 5 days. 7-ethoxyresorufin, tolbutamide, bufuralol, and midazolam were used as CYP1A, CYP2C, CYP2D, and CYP3A substrates, respectively. Concentrations of metabolites formed by CYPs were measured by use of high-performance liquid chromatography, except for the resorufin concentrations measured by use of a fluorometric method. Reaction velocity-substrate concentration data were analyzed to obtain maximum reaction velocity (V<jats:sub>max<\/jats:sub>) and Michaelis-Menten constant (K<jats:sub>m<\/jats:sub>).<\/jats:p>\n<jats:p><jats:bold>Results<\/jats:bold>\u2014Values of V<jats:sub>max<\/jats:sub> for midazolam 4-hydroxylation were significantly decreased by treatment with DEX at 2.5 and 7.5 mg in dogs, although values of K<jats:sub>m<\/jats:sub> were not affected. Values of V<jats:sub>max<\/jats:sub> for bufuralol 1'-hydroxylation were also decreased by treatment with DEX. In rats, values of V<jats:sub>max<\/jats:sub> for midazolam 4- hydroxylation were significantly decreased by treatment with DEX at 0.75 and 6 mg\/kg but significantly increased at 48 mg\/kg. Other reactions were not affected by treatment with DEX.<\/jats:p>\n<jats:p><jats:bold>Conclusions and Clinical Relevance<\/jats:bold>\u2014Our results indicate that DEX downregulates the CYP3A subfamily when administered at clinically relevant doses to dogs. The effect of downregulation of CYP3A in dogs treated with DEX should be considered to avoid adverse effects from coadministration of drugs.<\/jats:p>","DOI":"10.2460\/ajvr.67.2.329","type":"journal-article","created":{"date-parts":[[2006,2,2]],"date-time":"2006-02-02T15:43:42Z","timestamp":1138895022000},"page":"329-334","source":"Crossref","is-referenced-by-count":9,"title":["Effect of oral administration of clinically relevant doses of dexamethasone on regulation of cytochrome P450 subfamilies in hepatic microsomes from dogs and rats"],"prefix":"10.2460","volume":"67","author":[{"given":"Kewei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Kuroha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Kokue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"key":"ref1","series-title":"Biochem Soc Trans","doi-asserted-by":"publisher","first-page":"131S","DOI":"10.1042\/bst022131s","article-title":"Induction of CYP3A enzymes in human and rat hepatocyte cultures","volume":"22","author":"Williams","year":"1994"},{"key":"ref2","series-title":"Xenobiotica","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/0049825021000012655","article-title":"Differential induction of midazolam metabolism in the small intestine and liver by oral and intravenous dexamethasone pretreatment in rat","volume":"32","author":"Eeckhoudt","year":"2002"},{"key":"ref3","series-title":"Xenobiotica","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/0049825031000085960","article-title":"Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A sub-family form mRNAs in vivo and in vitro using precision-cut rat liver slices","volume":"33","author":"Meredith","year":"2003"},{"key":"ref4","series-title":"Chem Biol Interact","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0009-2797(01)00162-4","article-title":"Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog","volume":"134","author":"Lu","year":"2001"},{"key":"ref5","series-title":"Biochem Mol Biol Int","first-page":"1135","article-title":"Induction of hepatic microsomal cytochrome P450 by dexamethasone in rhesus monkey (Macaca mulatta)","volume":"33","author":"Ojha","year":"1994"},{"key":"ref6","series-title":"Br J Pharmacol","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2125.1996.tb00153.x","article-title":"Cyclophosphamide pharmacokinetics in children","volume":"41","author":"Yule","year":"1996"},{"key":"ref7","series-title":"Small animal clinical pharmacology and therapeutics","first-page":"733","article-title":"Drug dosage tables","author":"Boothe","year":"2001"},{"key":"ref8","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1016\/S0021-9258(19)42253-9","article-title":"Preparation and properties of partially purified Cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes","volume":"249","author":"Van der Hoeven","year":"1974"},{"key":"ref9","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951"},{"key":"ref10","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","article-title":"The carbon monoxide-binding pigment of liver microsomes: I. Evidence for its hemoprotein nature","volume":"239","author":"Omura","year":"1964"},{"key":"ref11","series-title":"Biochem Pharmacol","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1016\/0006-2952(85)90355-7","article-title":"Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450","volume":"34","author":"Burke","year":"1985"},{"key":"ref12","series-title":"J Chromatogr B Biomed Sci Appl","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0378-4347(00)00278-4","article-title":"Determination of cytochrome P450 1A activities in mammalian liver microsomes by high-performance liquid chromatography with fluorescence detection","volume":"744","author":"Hanioka","year":"2000"},{"key":"ref13","series-title":"Drug Metab Dispos","first-page":"354","article-title":"CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes","volume":"28","author":"Wester","year":"2000"},{"key":"ref14","series-title":"Chem Biol Interact","first-page":"243","article-title":"A comparison of aroclor 1254-induced and uninduced rat liver microsomes to human liver microsomes in phenytoin O-deethylation, coumarin 7-hydroxylation, tolbutamide 4-hydroxylation, S-mephenytoin 4\u2032-hydroxylation, chloroxazone 6-hydroxylation and testosterone 6beta-hydroxylation","volume":"134","author":"Easterbrook","year":"2001"},{"key":"ref15","series-title":"Methods Enzymol","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0076-6879(91)06120-R","article-title":"Bufuralol, dextromethorphan, and debrisoquine as prototype substrates for human P450IID6","volume":"206","author":"Kronbach","year":"1991"},{"key":"ref16","series-title":"Drug Metab Dispos","first-page":"188","article-title":"Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver","volume":"27","author":"Chow","year":"1999"},{"key":"ref17","series-title":"Ther Drug Monit","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/00007691-199806000-00013","article-title":"Analysis of midazolam and metabolites in plasma by high-performance liquid chromatography: probe of CYP3A","volume":"20","author":"Carrillo","year":"1998"},{"key":"ref18","series-title":"Am J Vet Res","doi-asserted-by":"publisher","first-page":"900","DOI":"10.2460\/ajvr.2002.63.900","article-title":"In vitro characterization of the inhibitory effects of ketoconazole on metabolic activities of cytochrome P-450 in canine hepatic microsomes","volume":"63","author":"Kuroha","year":"2002"},{"key":"ref19","series-title":"J Pharmacobiodyn","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1248\/bpb1978.4.879","article-title":"A pharmacokinetic analysis program (MULTI) for microcomputer","volume":"4","author":"Yamaoka","year":"1981"},{"key":"ref20","series-title":"Drug Metab Dispos","first-page":"353","article-title":"Differential induction of rat hepatic cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in response to pyridine treatment","volume":"29","author":"Kim","year":"2001"},{"key":"ref21","series-title":"Mol Pharmacol","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1124\/mol.58.2.361","article-title":"Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators","volume":"58","author":"Pascussi","year":"2000"},{"key":"ref22","series-title":"Mol Pharmacol","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1124\/mol.58.6.1441","article-title":"Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation","volume":"58","author":"Pascussi","year":"2000"},{"key":"ref23","series-title":"Eur J Biochem","doi-asserted-by":"publisher","first-page":"6346","DOI":"10.1046\/j.0014-2956.2001.02540.x","article-title":"Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor","volume":"268","author":"Pascussi","year":"2001"},{"key":"ref24","series-title":"Xenobiotica","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1080\/00498250210144811","article-title":"Permissive and suppressive effects of dexamethasone on enzyme induction in hepatocyte co-cultures","volume":"32","author":"Ringel","year":"2002"}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/67\/2\/ajvr.67.2.329.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/67\/2\/ajvr.67.2.329.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/67\/2\/ajvr.67.2.329.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:13:43Z","timestamp":1741349623000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/67\/2\/ajvr.67.2.329.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":24,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.67.2.329","relation":{},"ISSN":["0002-9645"],"issn-type":[{"type":"print","value":"0002-9645"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}